Chemotherapy-Induced Nausea and Vomiting and cannabis in Illinois
The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.
- ✗ No
- LEGAL
- 2.5 oz per 14-day suppl…
- POSSESSION
- $100/yr
- STATE FEE
- 14–45 d
- TIMELINE
Illinois statute and program
The Illinois Compassionate Use of Medical Cannabis Program is the operating authority for Illinois patient certification. The authoritative legal text is: Illinois Cannabis Regulation and Tax Act (410 ILCS 705). The program portal is at Illinois Compassionate Use of Medical Cannabis Program.
What the evidence says about cannabis and Chemotherapy-Induced Nausea and Vomiting
Two oral synthetic cannabinoids (dronabinol and nabilone) are FDA-approved for chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetic therapy. The 2017 NASEM consensus report concluded that there is substantial evidence supporting their effectiveness in adults.
For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Chemotherapy-Induced Nausea and Vomiting page.
How to qualify in Illinois
The Illinois Compassionate Use of Medical Cannabis Program requires the following registration steps for a Chemotherapy-Induced Nausea and Vomiting patient (or any qualifying diagnosis):
- Get a written certification from an Illinois-licensed physician. Any Illinois-licensed physician, advanced practice registered nurse, or physician assistant authorized to prescribe Schedule II controlled substances may issue a written certification under the Compassionate Use of Medical Cannabis Program Act (410 ILCS 130/). The Opioid Alternative Pilot Program (OAPP, expanded under PA 100-1114) allows any patient prescribed an opioid for a medical condition to use medical cannabis as an alternative.
- Apply through the Illinois Department of Public Health portal. The patient creates an account in the Illinois Department of Public Health (IDPH) Medical Cannabis Patient Registry, uploads a current Illinois driver license or state ID, a passport-style photograph, the physician written certification, and proof of Illinois residency. The application may be submitted online or by mail.
- Pay the state registration fee. The Illinois patient registration card fee is $100 per year, $200 for two years, or $250 for three years. Reduced fees of $50 / $100 / $125 apply for patients receiving SSI or SSDI disability benefits, and veterans pay no patient registration fee. Caregivers pay a separate $50 fee and complete a state and federal background check.
- Receive the card and purchase from an Illinois dispensary. Illinois medical cannabis patient registry cards are issued within roughly 30 days of complete application. With the card, patients may purchase up to 2.5 ounces every 14 days from any of the licensed Illinois medical cannabis dispensaries (most of which are co-located with adult-use retail). Adult-use is legal statewide for adults 21+; medical patients retain lower taxation, higher purchase limits, and product-availability priority during shortages.
- State registration fee
- $100
- Physician visit (typical)
- $200–$350
- Certification to card
- 14–45 days
- Out-of-state patients
- Not eligible
- Minors
- Eligible with caregiver
For full Illinois registration steps, fees, and reciprocity rules, see the Illinois cannabis-laws page.
ICD-10 code
A certifying physician documenting Chemotherapy-Induced Nausea and Vomiting for the Illinois medical cannabis program will typically record ICD-10 R11.2 or SNOMED-CT 422587007 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.
Frequently asked questions
Does Illinois list Chemotherapy-Induced Nausea and Vomiting as a qualifying condition for medical cannabis?
No. Illinois's qualifying-condition list does not currently include Chemotherapy-Induced Nausea and Vomiting, and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Chemotherapy-Induced Nausea and Vomiting in Illinois have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. Illinois program rules change, so verify the current list with the regulator before drawing a final conclusion.
How do I get a Illinois medical marijuana card for Chemotherapy-Induced Nausea and Vomiting?
Because Illinois does not currently list Chemotherapy-Induced Nausea and Vomiting as a qualifying condition, a card for Chemotherapy-Induced Nausea and Vomiting alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in Illinois who is registered with Illinois Compassionate Use of Medical Cannabis Program and willing to evaluate Chemotherapy-Induced Nausea and Vomiting cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Illinois does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the Illinois Compassionate Use of Medical Cannabis Program site at https://dph.illinois.gov/topics-services/prevention-wellness/medical-cannabis; the state updates fees, forms, and physician registration rules periodically.
What does the evidence say about cannabis for Chemotherapy-Induced Nausea and Vomiting?
For Chemotherapy-Induced Nausea and Vomiting, evidence is described as strong (e.g. multiple randomized controlled trials or systematic reviews supporting effect). The mmjnow condition page for Chemotherapy-Induced Nausea and Vomiting lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Chemotherapy-Induced Nausea and Vomiting should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Chemotherapy-Induced Nausea and Vomiting and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Chemotherapy-Induced Nausea and Vomiting; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.
Sources
- Illinois Cannabis Regulation and Tax Act (410 ILCS 705)accessed May 15, 2026
- IDFPR: Adult Use Cannabis Programaccessed May 16, 2026
- Illinois DPH: Medical Cannabis Patient Programaccessed May 16, 2026
- NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 14, 2026
“Conclusive or substantial evidence that oral cannabinoids are effective antiemetics in the treatment of chemotherapy-induced nausea and vomiting.”
- NIH NCCIH: Cannabis (Marijuana) and Cannabinoidsaccessed May 14, 2026